Miscellaneous Complications

  • Mary E. Maloney
  • Nathaniel J. Jellinek


This chapter will cover a wide variety of complications without a common uniting theme. Some topics are well established in the literature, whereas others are well recognized, common problems that have not been researched extensively. References may be sparse or nonexistent in some areas. These miscellaneous complications are still important and the cutaneous surgeon should be capable of avoiding them before they occur and treating them once they arise.


Contact Dermatitis Complex Regional Pain Syndrome Allergic Contact Dermatitis Topical Antibiotic Nasal Valve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lawlor K, Taylor JS. Contact allergy. In: Wheeland RG, ed. Cutaneous surgery. Philadelphia: Saunders; 1994:76–90.Google Scholar
  2. 2.
    Marks JG, Rainey MA. Cutaneous reactions to surgical preparations and dressings. Contact Dermatitis 1984;10:1–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Reynolds NJ, Harman RRM. Allergic contact dermatitis from chlorhexidine diacetate in a skin swab. Contact Dermatitis 1990;22:103–128.CrossRefPubMedGoogle Scholar
  4. 4.
    Lasthein AB, Brandrup F. Contact dermatitis from chlorhexidine. Contact Dermatitis 1985;13:307–309.CrossRefGoogle Scholar
  5. 5.
    Osmundsen PE. Contact dermatitis to chlorhexidine. Contact Dermatitis 1982;8:81–83.CrossRefPubMedGoogle Scholar
  6. 6.
    Rietschel RL, Fowler JF. Antiseptics and disinfectants. In: Rietschel RL, Fowler JF, eds. Fisher’s contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:162–163.Google Scholar
  7. 7.
    Goon AT, White IR, Rycroft RJ, et al. Allergic contact dermatitis from chlorhexidine. Dermatitis 2004;15:45–47.PubMedGoogle Scholar
  8. 8.
    Kautheim AB, Jermann THM, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004;50:113–116.CrossRefGoogle Scholar
  9. 9.
    Beaudouin E, Kanny G, Morisset M, et al. Immediate hyper-sensitivity to chlorhexidone: literature review. Allerg Immunol (Paris) 2004;36:123–126.Google Scholar
  10. 10.
    Snellman E, Rantanen T. Severe anaphylaxis after a chlorhexidine bath. J Am Acad Dermatol 1999;40:771–772.CrossRefPubMedGoogle Scholar
  11. 11.
    Autegarden JE, Pecquet E, Huet S, et al. Anaphylactic shock after application of chlorhexidine to unbroken skin. Contact Dermatitis 1999;40:215.CrossRefPubMedGoogle Scholar
  12. 12.
    Bergqvist-Karlsson A. Delayed and immediate-type huper-sensitivity to chlorhexidone. Contact Dermatitis 1988;18:84–88.CrossRefPubMedGoogle Scholar
  13. 13.
    Lauerma AI. Simultaneous immediate and delayed hyper-sensitivity to chlorhexidine digluconate. Contact Dermatitis 2001;44:59.CrossRefPubMedGoogle Scholar
  14. 14.
    Nasser RE. The ocular danger of Hibiclens (chlorhexidine). Plast Reconstr Surg 1992;89:164–165.PubMedGoogle Scholar
  15. 15.
    Igarashi Y, Suzuki J. Toxicity of chlorhexidine gluconate in cats. Arch Otorhinolaryngol 1985;242:167–176.CrossRefPubMedGoogle Scholar
  16. 16.
    Igarash Y, Oka Y. Vestibular ototoxicity following intratympanic applications of chlorhexidine gluconate in the cat. Arch Otorhinolaryngol 1988;245:210–217.CrossRefGoogle Scholar
  17. 17.
    Marks JG. Allergic contact dermatitis to poidone-iodine. J Am Acad Dermatol 1982;6:473–475.CrossRefPubMedGoogle Scholar
  18. 18.
    Corazza M, Bulciolu G, Spisanil L, et al. Chemical burns following irritant contact with providone-iodine. Contact Dermatitis 1997;36:115–116.CrossRefPubMedGoogle Scholar
  19. 19.
    Pietsch J, Meakins JL. Complications of povidone-iodine absorption in topically treated burn patients. Lancet 1976;1:280–282.CrossRefPubMedGoogle Scholar
  20. 20.
    Bishop ME, Garcia RL. Iododerma from wound irrigation with povidone-iodine. JAMA 1978;240:249–250.CrossRefPubMedGoogle Scholar
  21. 21.
    Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985;120:267–270.PubMedGoogle Scholar
  22. 22.
    Rietschel RL, Fowler JF. Contact dermatitis in health personnel. In: Rietschel RL, Fowler JF, eds. Fisher’s contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:451–465.Google Scholar
  23. 23.
    Ludwig E, Hansen BM. Sensitivity to isopropyl alcohol. Contact Dermatitis 1977;3:240–244.CrossRefPubMedGoogle Scholar
  24. 24.
    Melli MC, Giorgini S, Sertoli A. Sensitization from contact with ethyl alcohol. Contact Dermatitis 1986;14:315.CrossRefPubMedGoogle Scholar
  25. 25.
    Kanzaki T, Hori H. Late phase allergic reaction of the skin to ethyl alcohol. Contact Dermatitis 1991;25:252–253.CrossRefPubMedGoogle Scholar
  26. 26.
    VanKetel WG, Tan-Lim KN. Contact dermatitis from ethanol. Contact Dermatitis 1975;1:7.CrossRefGoogle Scholar
  27. 27.
    Marks JG, Belsito DV, Fowler JF, et al. North American Contact Dermatitis Group patch test results, 1996–1998. Arch Dermtol 2000;136:272–273.CrossRefGoogle Scholar
  28. 28.
    Fraki J, Petonen L, Hopsu-Havu K. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis 1979;5:97–100.CrossRefPubMedGoogle Scholar
  29. 29.
    Prystowsky S, Nonomura J, Smith R, et al. Allergic hypersensivitiy to neomycin. Arch Dermatol 1979;115:713–715.CrossRefPubMedGoogle Scholar
  30. 30.
    Prystowsky S, Nonamura J, Smith R, et al. Contact allergy to various components of topical preparations for treatment of external obitis. Acta Otolaryngol 1985;100:414–418.CrossRefGoogle Scholar
  31. 31.
    Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. JAMA 1979;242:1276–1278.CrossRefPubMedGoogle Scholar
  32. 32.
    Rietschel RL, Fowler JF. Reactions to topical antimicobials. In: Rietschel RL, Fowler JF, eds. Fisher’s contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:167–184.Google Scholar
  33. 33.
    Katz B, Fisher A. Bacitracin: a unique topical antibiotic sensitizer. J Am Acad Dermatol 1987;17:1016–1024.CrossRefPubMedGoogle Scholar
  34. 34.
    Epstein S, Wenzel FJ. Cross-sensitivity to various “mycins”. Arch Dermatol 1962;86:183–194PubMedGoogle Scholar
  35. 35.
    Pirla V, Forstrom L, Rouhunkoski S. Twelve years of sensitization to neomycin in Finland. Acta Derm Venercol 1967;47:419–425.Google Scholar
  36. 36.
    Roup G, Stennegard O. Anaphylactic shock elicited by topical administration of bacitracin. Arch Dermatol 1969;100:450–452.CrossRefGoogle Scholar
  37. 37.
    Elsner P, Penny I, Burg G. Anaphylaxis induced by topically applied bacitracini. Am J Contact Derm 1990;1:162–164.Google Scholar
  38. 38.
    Schecter J, Wilkinson R, Carpio J. Anaphylaxis following the use of bacitracin ointment. Arch Dermatol 1984;120:909–911.CrossRefGoogle Scholar
  39. 39.
    Zappi E, Brancaccio RR. Allergic contact dermatitis from Mupirocin ointment. J Am Acad Dermatol 1997;36:266–267.CrossRefPubMedGoogle Scholar
  40. 40.
    VanKetel WG. Polymixine 8-sulfate and bacitracin. Contact Dermatitis News 1974;15:445.Google Scholar
  41. 41.
    Gette MT, Marks JG, Maloney ME. Frequency of post operative allergic contact dermatitits to topical antibiotics. Arch Dermtol 1992;128:365–367.CrossRefGoogle Scholar
  42. 42.
    Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs. bacitracin ointment. JAMA 1996;276:972–977.CrossRefPubMedGoogle Scholar
  43. 43.
    Clark RAF. Cutaneous tissue repair; basic biologic considerations I. J Am Acad Dermatol 1985;13:701–725.CrossRefPubMedGoogle Scholar
  44. 44.
    Drake DB, Rodeheaver PF, Edlich RF, et al. Experimental studies in swine for measurement of suture extrusion. J Long Term Eff Med Implants 2004;14:251–259.CrossRefPubMedGoogle Scholar
  45. 45.
    Dufresne RG. Surgical complication: prevention, recognition, and treatment. In: Ratz JL, ed. Textbook of dermatologic surgery. Philadelphia: Lippincott-Raven; 1998:59–73.Google Scholar
  46. 46.
    Haneke E, Baran R. Longitudinal melanonychia. Dermatol Surg 2001;27:580–584.PubMedGoogle Scholar
  47. 47.
    Laffitte E, Gurkan K, Piguet V, et al. Erosive pusturlar dematosis of the scalp: treatment with topical tacrolimus. Arch Dermatol 2003;139:712–714.CrossRefPubMedGoogle Scholar
  48. 48.
    Weinstein C, Ramirez OM, Pozner JN. Postoperative care following CO2 laser resurfacing: avoiding pitfalls. Plast Reconstr Surg 1997;100:1855–1866.CrossRefPubMedGoogle Scholar
  49. 49.
    Nanni CA, Alster TS. Complications of cargon dioxide laser resurfacing: an evaluation of 500 patients. Dermatol Surg 1998;24:315–320.CrossRefPubMedGoogle Scholar
  50. 50.
    Hebda PA, Lee CI. Occlusine dressings for surgical and other acute wounds. Wounds 1992;4:84–87.Google Scholar
  51. 51.
    Phelps RG, Wilentz S. Reflex sympathetic dystrophy. Int J Dermatol 2000;39:481–486.CrossRefPubMedGoogle Scholar
  52. 52.
    Turner-Stokes L. Reflex sympathetic dystrophy — a complex regional pain syndrome. Disabil Rehabil 2002;24:939–947.CrossRefPubMedGoogle Scholar
  53. 53.
    Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;371:738–746.CrossRefGoogle Scholar
  54. 54.
    Clark RAF. Basics of cutaneous wound repair. J Dermatol Surg Oncol 1993;19:693–706.PubMedGoogle Scholar
  55. 55.
    Herman E. Itching in scars. In: Berhhard JB, ed. Itch: mechanisms and management of pruritus. New York: McGraw-Hill; 1994:153–160.Google Scholar
  56. 56.
    Cohen IK, Beaver MA, Horakova Z, et al. Histamine and collagen synthesis in keloid and hypertrophic scar. Surg Forum 1972;23:509–510.PubMedGoogle Scholar
  57. 57.
    Burton CS. Dermal hypertrophies. In: Bolognia JL, Jorizzo JL, Rapini RP, ed. Dermatology. New York: Mosby; 2003:1531–1537.Google Scholar
  58. 58.
    Remensnyder JP, Majno G. Oxygen gradients in healing wounds. Am J Pathol 1968;52:301–323.PubMedGoogle Scholar
  59. 59.
    Kosmadaki MG, Yaar M, Arble BL, Gilchrest BA. UV induces VEGF through a TNF-alpha independent pathway. Fed Am Soc Exp Biol J 2003;17:446–448.Google Scholar
  60. 60.
    DeLara Galindo S, Cuspinera E, Ramirez LC. Anatomical and functional account of the lateral nasal cartilages. Acta Anat 1977;97:393–399.CrossRefGoogle Scholar
  61. 61.
    Howard B, Rohrich R. Understanding the nasal airway: principles and practice. Plast Reconstr Surg 2002;109:1128–1146.CrossRefPubMedGoogle Scholar
  62. 62.
    Robinson JK, Burget GC. Nasal valve malfunction resulting from resection of cancer. Arch Otolaryngol Head Neck Surg 1990;116:1419–1424.PubMedGoogle Scholar
  63. 63.
    Jones E, Youker S, Fosko S. A nasal trumpet orthosis to maintain nares opening during a melolabial interpolation flap. Dermatol Surg 2006;32(1):96–99.PubMedCrossRefGoogle Scholar
  64. 64.
    Karen M, Chang E, Keen MS. Auricular composite grafting to repair nasal vesibular stenosis. Otolaryngol Head Nec Surg 2000;122:529–532.CrossRefGoogle Scholar
  65. 65.
    Friedman M, Ibrahim H, Syed Z. Nasal valve suspension: an improved, simplified technique for nasal valve collapse. Laryngoscope 2003;113:381–385.CrossRefPubMedGoogle Scholar
  66. 66.
    Rizvi SS, Gauthier MG. How I do it: lateralizing the collapsed nasal valve. Laryngoscope 2003;113:2052–2054.CrossRefPubMedGoogle Scholar
  67. 67.
    Zacarian SA. Cryosurgery of cutaneous carcinoma. J Am Acad Dermatol 1983;9:947–956.CrossRefPubMedGoogle Scholar
  68. 68.
    Skouge JW. Skin grafting. New York: Churchill Livingstone; 1991:44–45, 61–63.Google Scholar
  69. 69.
    Stratigos AJ, Dover JS, Arndt KA. Laser therapy. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. New York: Mosby; 2003:2153–2175.Google Scholar
  70. 70.
    Waldorf HA, Kauvar ANB, Geroneumus RG. Skin resurfacing of fine to deep rhytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg 1995;21:940–946.CrossRefPubMedGoogle Scholar
  71. 71.
    Ho C, Nguyen Q, Lowe NJ, et al. Laser resurfacing in pigmented skin. Dermatol Surg 1995;21:1035–1037.CrossRefPubMedGoogle Scholar
  72. 72.
    Goldberg DJ. Complications in cutaneous laser surgery. New York: Taylor & Francis; 2004.Google Scholar
  73. 73.
    Bernstein LJ, Kauvar AB, Grossman MC, Geronemus RG. The short and long term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997;23:519–525.CrossRefPubMedGoogle Scholar
  74. 74.
    Goldman MP, Bergow JJ. Complications and adverse sequelae of sclerotherapy. In: Sclerotherapy: treatment of varicose and telangiectatic leg veins. 3rd ed. St Louis: Mosby; 2001:191–197.Google Scholar
  75. 75.
    Georgiev M. Post sclerotherpy hyperpigmentation: a oneyear follow up. J Dermatol Surg Oncol 1990;16:608.PubMedGoogle Scholar
  76. 76.
    Ramelet AA. Complications of ambulatory phlebectomy. Dermatol Surg 1997;23:947–954.CrossRefPubMedGoogle Scholar
  77. 77.
    Weiss RA, Sadick NS, Goldman MP, et al. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25:105.CrossRefPubMedGoogle Scholar
  78. 78.
    Myers HL. Topical chelation therapy for varicose pigmentation. Angiology 1966;17:66.CrossRefPubMedGoogle Scholar
  79. 79.
    Goldman MP. Post sclerotherapy hyperpigmentation treatment with a flash-lamp excited pulsed dye laser. J Dermatol Surg Oncol 1992;18:417.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Mary E. Maloney
    • 1
  • Nathaniel J. Jellinek
    • 2
  1. 1.Division of DermatologyUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Brown Medical SchoolProvidenceUSA

Personalised recommendations